Found: 8
Select item for more details and to access through your institution.
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 1, p. 63, doi. 10.1007/s10549-019-05216-w
- By:
- Publication type:
- Article
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 2, p. 387, doi. 10.1007/s10549-018-05085-9
- By:
- Publication type:
- Article
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 712, doi. 10.3390/cancers12030712
- By:
- Publication type:
- Article
A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy.
- Published in:
- Oncology & Therapy, 2020, v. 8, n. 1, p. 1, doi. 10.1007/s40487-019-00105-0
- By:
- Publication type:
- Article
Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation.
- Published in:
- Oncology & Therapy, 2018, v. 6, n. 2, p. 141, doi. 10.1007/s40487-018-0062-x
- By:
- Publication type:
- Article